U.S.-based Ipseity Diagnostics Partners with Vignan University to advance molecular research in Andhra Pradesh

In order to provide a significant boost to biomedical innovation in Andhra Pradesh, Ipseity Diagnostics and Research, a US-based molecular diagnostics company, has entered into a scientific collaboration with Vignan’s Foundation for Science, Technology and Research. The partnership aims to bring transcriptomics, low-cost PCR technologies and Next Generation Sequencing (NGS) to the State, marking a significant step towards strengthening advanced molecular research capabilities.

The Memorandum of Understanding (MoU) was formally exchanged at the University campus on Friday, December 12, 2025, in the presence of President Lavu Rathaiah, Vice-Chancellor P. Nagabhushan and Adviser M. Malakondaiah. Representing Ipseity Diagnostics, CEO Dr. Sandeep Nadendla and CMO Dr. Kalyan Chakravarthy K., Prof. from Vignan Foundation. PMV Rao and Prof. Vijaya Ramu signed the deal with Dirisala.

According to the institutions, the collaboration is expected to accelerate efforts to bring molecular science “from bench to bedside,” providing new diagnostic solutions for patients suffering from sepsis, drug-resistant and uncontrolled infections, and other critical illnesses. The research initiative also aims to develop indigenous, affordable technologies tailored to the needs of the Indian healthcare system.

Dr. Kalyan Chakravarthy said the partnership positions Andhra Pradesh as an emerging hub for cutting-edge biomedical research and can benefit millions of patients with faster, more accurate and affordable diagnostic tools.